ClinicalTrials.Veeva
Menu

Find clinical trials for Alzheimer's Disease in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Alzheimer Disease
Dementia
Cognitive Dysfunction
Mental Disorders
Brain Diseases
Nervous System Diseases
Central Nervous System Diseases

Alzheimer's Disease trials near Berlin, BE, DEU:

Locations recently updated

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

This is a multicentre, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in p...

Enrolling
Alzheimer's Disease
Biological: VHB937
Other: Placebo

Phase 2

Novartis
Novartis

Berlin, Germany and 49 other locations

Alzheimer's disease (AD) is the most common form of dementia. In the brains of people with AD, certain small substances stick toget ...

Active, not recruiting
Mild Cognitive Impairment Due to Alzheimer's Disease
Alzheimer's Disease, Early Onset
Drug: Placebo
Drug: PRI-002

Phase 2

PRInnovation

Berlin, Germany and 37 other locations

administered once every four weeks (Q4W) in slowing cognitive and functional decline as compared to placebo in participants with early Alzheimer's...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: sabirnetug

Phase 2

Acumen Pharmaceuticals

Berlin, Germany and 72 other locations

The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease...

Enrolling
Alzheimer's Disease
Other: Placebo
Drug: KarXT

Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Berlin, Germany and 109 other locations

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determin...

Active, not recruiting
Early Alzheimer's Disease
Drug: Lecanemab SC
Drug: Lecanemab IV

Phase 3

Eisai
Eisai

Berlin, Germany and 246 other locations

The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease...

Enrolling
Alzheimers Disease
Drug: Trontinemab
Other: Placebo

Phase 3

Roche
Roche

Steglitz, Germany and 119 other locations

The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease...

Enrolling
Alzheimer Disease
Drug: Placebo
Drug: KarXT

Phase 3

Karuna Therapeutics
Karuna Therapeutics

Berlin, Germany and 281 other locations

The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease...

Enrolling
Alzheimers Disease
Drug: Trontinemab
Other: Placebo

Phase 3

Roche
Roche

Berlin, Germany and 134 other locations

This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to e...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: AR1001

Phase 3

AriBio

Berlin, Germany and 199 other locations

This clinical trial is recruiting people who either are at risk of AD - have build-up of beta-amyloid, but have no clinical symptoms, or with a diagn...

Active, not recruiting
Alzheimer's Disease
Drug: RO7269162
Drug: Placebo

Phase 2

Roche
Roche

Berlin, Germany and 47 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems